Remember that needing to restart or continue GLP-1 therapy is not a failureobesity and type 2 diabetes are chronic conditions that often require long-term medical management alongside lifestyle measures
In the STEP 1 trial of the Wegovy injection, nausea affected around 44% of people, diarrhoea around 30%, and vomiting around 25%
The body may interpret mild thirst as a need for food, especially sugary foods that provide fast energy
Tirzepatide produced 22.5% weight loss at its highest dose over 72 weeks in SURMOUNT-1
However, theres no evidence at this time that GLP-1 medications give any direct competitive advantage, according to Guiteau
If you become pregnant while taking semaglutide, stop immediately and notify your healthcare provider